Twenty-six young investigators join the EMBO community
EMBO welcomes 26 new members of the EMBO Young Investigator Network
8 December 2021 – EMBO congratulates 26 life scientists on their selection to the young investigator programme. They will join a network of 130 current and 368 former members of the programme. Starting in January 2022, the new young investigators will have access to a variety of networking opportunities and funding.
“We are pleased to welcome the 26 young investigators to the EMBO community,” says Michael N. Hall, EMBO Director ad interim. “They have already demonstrated scientific excellence despite only recently launching their own laboratories. The EMBO Young Investigator Programme will aid them in taking their career to the next level. We look forward to supporting them during an important phase of their career.”
As part of the programme, EMBO Young Investigators benefit from a variety of networking and training opportunities and have access to core facilities at the European Molecular Biology Laboratory (EMBL) in Heidelberg, Germany. They also receive a financial award of 15,000 euros and can apply for additional grants of up to 10,000 euros per year. The young investigators are active members in the programme for four years.
The EMBO Young Investigator Programme supports life scientists who have an excellent track record and have been group leaders for at least one but less than four years. They must carry out their research in an EMBC Member State, an EMBC Associate Member State (currently India and Singapore) or in countries or territories covered by a co-operation agreement (currently Taiwan and Chile).
Twelve of the new EMBO Young Investigators are female (46%) and 14 are male (54%). This year’s young investigators are based in seven EMBC Member States and the EMBC Associate Member State Singapore. The programme received 194 eligible applications and the success rate was 13%.
The next application deadline is 1 April 2022. More information about the programme, including eligibility criteria and the application process, is available at: https://www.embo.org/funding/fellowships-grants-and-career-support/young-investigator-programme/
EMBO Young Investigator Research Interest Affiliation Location
Anna Obenauf Therapies for metastatic cancers Research Institute of Molecular Pathology Vienna, AT
Benjamin Schumann Tools for quantitative glycobiology Francis Crick Institute London, UK
Celine Vallot Epigenomic evolution of breast cancers Institut Curie Paris, FR
Christian Münch Mammalian mitochondrial unfolded protein response Goethe University Frankfurt, DE
Clemens Plaschka mRNA processing and regulation Research Institute of Molecular Pathology Vienna, AT
Danny Nedialkova Context-specific regulation of protein biogenesis Max Planck Institute of Biochemistry Martinsried, DE
Darío Lupiáñez 3D regulatory landscapes in development and evolution Max Delbrück Centre for Molecular Medicine Berlin, DE
David Zwicker Physical principles of the organization of cellular structures Max Planck Institute for Dynamics and Self-Organization Göttingen, DE
Edda Schulz Quantitative signal processing by gene networks and cis-regulatory landscapes Max Planck Institute for Molecular Genetics Berlin, DE
Elvan Böke Oocyte biology and cellular dormancy Centre for Genomic Regulation Barcelona, ES
Elvira Mass Developmental programming of the innate immune system University of Bonn Bonn, DE
Felipe Karam Teixeira Molecular mechanisms controlling and protecting the germline University of Cambridge Cambridge, UK
Florian Schur Structural biology of cell migration and viral Infection Institute of Science and Technology Austria Klosterneuburg, AT
Gray Camp Exploring uniquely human development
Roche Institute for Translational Bioengineering Basel and University of Basel Basel, CH
Katrin Franke Tracing visual computations from the retina to behaviour University of Tübingen Tübingen, DE
Lena Ho Micropeptides in metabolism and immunity Duke-NUS Medical School Singapore, SG
Melanie Hamon Bacteria mediated chromatin modifications in health and disease Institut Pasteur Paris, FR
Mounia Lagha Gene expression precision during development Institute of Molecular Genetics of Montpellier Montpellier, FR
Nina Cabezas-Wallscheid Regulation of haematopoietic stem cell dormancy Max Planck Institute of Immunobiology and Epigenetics Freiburg, DE
Ori Avinoam Dynamic membrane remodelling Weizmann Institute Rehovot, Israel
Pierre-Marc Delaux Evolution and functioning of plant symbioses Plant Science Research Laboratory Toulouse, FR
Pontus Skoglund Ancient genomics and human evolution Francis Crick Institute London, UK
Roger Geiger Systems analyses of anti-tumour T cell responses Institute for Research in Biomedicine Bellinzona, CH
Stefanie Jonas RNA processing machineries in the nucleus of human cells Swiss Federal Institute of Technology Zurich, CH
Uri Ben-David Functional consequences of aneuploidy in cancer Tel Aviv University Tel Aviv, IL
Yonatan Stelzer Dissecting early embryonic cell-fate decisions at spatio-temporal resolution Weizmann Institute Rehovot, IL
EMBO is an organization of more than 1,800 leading researchers that promotes excellence in the life sciences in Europe and beyond. The major goals of the organization are to support talented researchers at all stages of their careers, stimulate the exchange of scientific information, and help build a research environment where scientists can achieve their best work.
EMBO helps young scientists to advance their research, promote their international reputations and ensure their mobility. Courses, workshops, conferences, and scientific journals disseminate the latest research and offer training in techniques to maintain high standards of excellence in research practice. EMBO helps to shape science and research policy by seeking input and feedback from our community and by following closely the trends in science in Europe. For more information: www.embo.org